Foreign Filer Report • Nov 11, 2025
Foreign Filer Report
Open in ViewerOpens in native device viewer
Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934
For the Month of November 2025
001-36203 (Commission File Number)
(Exact name of Registrant as specified in its charter)
(Address of principal executive offices)
Form 20-F ☒ Form 40-F ☐
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
On November 10, 2025, a Special General Meeting of Shareholders of Can-Fite BioPharma Ltd. (the "Company") approved each of the two proposals brought before the Company's shareholders at the meeting, in accordance with the majority required for each proposal. Each of those proposals was described in the Company's Notice and Proxy Statement with respect to the Company's Special General Meeting of Shareholders, dated October 3, 2025, attached as Exhibit 99.1 to the Company's Form 6-K that was furnished to the U.S. Securities and Exchange Commission on October 3, 2025.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: November 10, 2025 By: /s/ Motti Farbstein
Motti Farbstein Chief Executive Officer and Chief Financial Officer
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.